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I Abstract 
 “The development of antibiotic resistance in bacteria has been attributed to 
the use of antimicrobials in human medicine. The contributions of veterinary medicine 
and agriculture to antibiotic resistance are still being investigated.”1   
Hence, there is pressure on analytical scientists to detect and confirm the presence of 
antimicrobials in foods of animal origin. The aminoglycosides and macrolides are two 
families of antibiotics that are very similar in structure and have important 
applications in veterinary medicine. These antibiotics are widely used in the treatment 
of bacterial infections e.g. aminoglycosides for enteritis and mastisis and macrolides 
for enteric infections. They have also been used as feed additives for growth 
promoting. As a result, legislation has been laid down by the European commission in 
which member states must meet strict criteria for monitoring these residues
2
. 
This thesis was undertaken to develop a UPLC-MS/MS method for the 
simultaneous analysis of the aminoglycoside and macrolide antibiotics.  This is the 
first time that a combination method for the two classes of compound was developed. 
A Waters Acquity/ Premier XE system with a dual ESI/APCI probe allowed for 
optimisation of detection for each component within a single run. For all target 
compounds the optimum MS ionisation mode and conditions were determined 
experimentally. The chromatographic conditions were investigated in order to 
improve separation, reduce analytical run times and meet validation requirements as 
per Commission Decision 2002/657/EC. While the scope of this thesis did not allow 
for the method to be expanded to cover the many sample matrices/ species that are 
required by the EU it is hoped that this will be investigated in the future. This thesis 
did however contain a comprehensive literature review of the current techniques 
employed to analyse for these residues both qualitatively and quantitatively. Sample 
preparation was researched and an extraction experiment was carried out comparing 
various solid phase extraction columns and discussed in detail in chapter 2. This 
experiment looked at various extraction methods to minimise matrix effects and 
optimise recoveries. Finally, the novel method developed and optimised for the 
analysis of the macrolide and aminoglycoside antibiotics using UPLC-MS/MS is 
presented. This will be applied to the analysis of real samples in the Central Meat 
Control laboratory which is a National Reference Laboratory (NRL) and expanded to 
cover the many species required for e.g. bovine, ovine and porcine tissues.  
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Chapter 1: An Introduction to the Aminoglycoside and 
Macrolide antibiotics used in animal products. 
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1.1. Background 
 
Aminoglycosides are a large class of antibiotics that are characterised by one 
or more amino sugars linked by glycosidic bonds to an aminocyclitol component. 
Aminoglycosides are classified according to the pattern of substitution of the cyclitol. 
The two most important subclasses are: 4, 5-disubstituted deoxystreptamine e.g. 
neomycin and 4, 6-disubstituted deoxystreptamine e.g. gentamicin, kanamycin
2
 
 
Figure 1.1 Some Aminoglycoside Structures, Streptomycin (MW 581.57 
C21H39N7O12) and Dihydrostreptomycin (MW 583.59 C21H41N7O12) 
The aminoglycosides are polycationic compounds that contain an 
aminocyclitol and an amino sugar joined to a ribose unit. The aminoglycosides 
interfere with bacterial protein synthesis by binding irreversible to ribosome and 
could cause cell membrane damages. Bacterial resistance enzymes may inactivate 
them but bacteria could also display resistance through ribosomal modifications or by 
decreased uptake of antibiotic into the bacterial cell. Aminoglycosides are widely 
distributed in the body after injection and little is absorbed from the gastro-intestinal 
tract. They are excreted unchanged in the urine. 
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Streptomycin (Figure 1.1) is an aminoglycoside antibiotic produced by 
Streptomyces griseus and it is active against many gram-negative bacteria. 
Streptomycin is used in veterinary medicine. If this antibiotic is incorrectly used, 
residues may be found in large concentrations in foodstuffs from animal origin and 
represent a risk for the consumer and (or) a disruptive element for the manufacturing 
processes adopted by the food industry.  
The macrolides are characterised by a macrocyclic lactone ring containing 14, 
15 or 16 atoms with sugars linked via glycosidic bonds
3
. The macrolides with 16 
atoms in the lactone ring represent the most commonly used macrolides in veterinary 
medicine and examples of these include tylosin (Figure 1.2) and spiramycin. 
Erythromycin (Figure 1.2) is another example of a macrolide antibiotic; it contains 14 
atoms
3
 and is produced by Streptomyces erythrues. It is active against gram-positive 
and some gram-negative bacteria
3
. Like the aminoglycosides the macrolide mode of 
action is protein synthesis inhibition, while the aminoglycosides bind to the 30S 
ribosomal subunit, the macrolides bind to the 50S ribosomal unit
4
.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: A Macrolide Structure, Spiramycin (MW 843.0 C43H74N2O14) 
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The Aminoglycoside and macrolide groups of antibiotics are used in 
veterinary medicine and animal husbandry particularly for treatment of bacterial 
infections for e.g. mastitis, or for prophylaxis. They are banned for used as growth 
promoters in the E.U. 
2
 Legislation monitoring these residues in live animals and 
animal products are given in E.U. Council Directive 96/23/EC
5
, S.I. 507/98 and E.U. 
Commission Decision 2002/657/EC
6
. 
In terms of their chemistries, the aminoglycosides are polar, resistant to acids, 
bases and heat and are not extensively bound to proteins
7
. Although some work has 
been carried out to date on this class of compound there is still huge potential for 
further research. The macrolides are more hydrophobic molecules and are unstable in 
acid
7
. The pKa values for the macrolides range from 7.4 for tylosin A to 8.8 for 
erythromycin
8
. They are soluble in methanol and range in molecular weight from 734 
amu for erythromycin to 916 amu for tylosin. 
 
 
1.2  Legislation 
 The increasing awareness of food safety by the consumer with respect to 
antimicrobial resistance has resulted in increasing pressure on laboratories responsible 
for food safety to monitor the use of these drugs and ensure the safety of food. There 
are increasingly resistant antibiotic strains of bacteria that are causing a threat to 
animal and human health. This interest is due primarily to the emergence and 
dissemination of multiple antibiotic resistant zoonotic bacterial pathogens
9
.  
As a result, to ensure that the aminoglycosides and macrolides are not used in 
non-approved situations and to control their use in meat producing animals, samples 
are taken at slaughterhouses and screened for the presence of residues. Analysis of 
positive screening tests for these residues in animal products must adhere to 
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legislation laid out in Council Directive 96/23/EC
5
, S.I. 507/98 Commission Decision 
2002/657/EC
6
 whereby suitable confirmatory methods are based on chromatographic 
analysis using spectrometric detection
6
.   
Council regulation (EEC) 2377/90
10
 of 26 June 1990 lays down the 
Community procedure for the establishment of maximum residue limits of veterinary 
medicinal products in foodstuffs of animal origin. See Table 1.1, 1.2 and 1.3 for 
details. Where a residue refers to: “all pharmacologically active substances, whether 
active principles, excipients or degradation products, and their metabolites which 
remain in foodstuffs obtained from animals to which the veterinary medicinal 
product in question has been administered.” 
The definition of maximum residue limit according to this regulation is given 
as: “the maximum concentration of residue resulting from the use of a veterinary 
medicinal product (expressed in mg/kg or μg/kg on a fresh weight basis) which may 
be accepted by the Community to be legally permitted or recognized as acceptable in 
or on a food.” 
Confirmatory methods for these compounds must provide information on the 
chemical structure of the analyte.  As a consequence methods that are based on 
chromatographic analysis only, without the use of spectrometric detection are 
unsuitable. However, if a single technique lacks the required specificity, a 
combination of techniques may be used. Table 1.4 details suitable confirmatory 
methods for the Aminoglycosides (Group B) compounds. A review paper by Rivier
11
 
details the criteria for the identification of compounds by LC/MS and LC/MS-MS and 
in particular the confirmation approach to comply with the European Union (EU) 
criteria for trace level organic analysis is presented.  
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Table 1.1 Pharmacologically active substances are divided into four 
Annex
10
  
Annex I Substances in respect of which maximum residue limits have 
been established. 
Annex II Substances for which it appears that it is not necessary for the 
protection of public health to establish maximum residue limits. 
Annex III Substances in respect of which provisional maximum residue 
limits have been established. 
Annex IV Where it appears that a maximum residue limit cannot be 
established in respect of a pharmacologically active substance 
used in veterinary medicinal products because residues of the 
substances concerned, at whatever limit, in foodstuffs of animal 
origin constitute a hazard to the health of the consumer 
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Table 1.2 Some aminoglycosides and macrolides with established 
MRL’s (Annex I)
10
  
Pharmacologically 
active substances 
Marker Residue Animal 
Species 
MRL’s Target 
Tissues 
Neomycin (including 
framycetin) 
Neomycin B All food 
producing 
species 
 
500 µg/kg Muscle 
500 µg/kg Fat 
500 µg/kg Liver 
5000 µg/kg Kidney 
1500 µg/kg Milk 
500µg/kg Eggs 
Kanamycin Kanamycin A All food 
producing 
species 
except fish 
100 µg/kg Muscle 
100 µg/kg Fat 
600 µg/kg Liver 
2500 µg/kg Kidney 
150 µg/kg Milk 
Erythromycin Erythromycin A All food 
producing 
species  
200 µg/kg Muscle 
200 µg/kg Fat 
200 µg/kg Liver 
200 µg/kg Kidney 
40 µg/kg Milk 
150 µg/kg Eggs 
 Gentamicin   Sum of Gentamicin 
C1, C1a, C2 and C2a 
Bovine 
Porcine  
 
 
 
Bovine 
50 µg/kg Muscle 
50 µg/kg Fat 
200 µg/kg Liver 
750 µg/kg Kidney 
100 µg/kg Milk 
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Table 1.2 Some aminoglycosides and macrolides with established 
MRL’s (Annex I) Contd
10
.  
Pharmacologically 
active substances 
Marker Residue Animal 
Species 
MRL’s Target 
Tissues 
Streptomycin Streptomycin All 
ruminants 
500 µg/kg Muscle 
500 µg/kg Fat 
500 µg/kg Liver 
1000 µg/kg Kidney 
200 µg/kg Milk 
 Tylosin  Tylosin A All food 
producing 
species 
100 µg/kg Muscle 
100 µg/kg Fat 
100 µg/kg Liver 
100 µg/kg Kidney 
50 µg/kg Milk 
200 µg/kg  Eggs 
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Table 1.3 Some aminoglycosides and macrolides with Provisional 
MRL’s (Annex III)
10 
Pharmacologically 
active substances 
 
Marker Residue Animal 
Species 
MRL’s Target 
Tissues 
Aminosidine 
(paromomycin) 
Aminosidine 
(paromomycin) 
Bovine 
Porcine 
Rabbits 
Chicken 
500 µg/kg Muscle 
1500 µg/kg Liver 
1500 µg/kg Kidney 
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Table 1.4 Suitable confirmatory methods for organic residues or 
contaminants
6 
 
Measuring 
Technique 
Substances Annex 1 
96/23/EC 
Limitations 
LC or GC with 
mass-spectrometric 
detection 
 
 
Groups A and B Only if following either an on-line or an 
off-line chromatographic 
Separation 
Only if full scan techniques are used or 
using atleast3 (group B) 
or 4 (group A) identification points for 
techniques that do not 
record the full mass spectra. 
LC or GC with IR 
spec detection 
Groups A and B Specific requirements for absorption in 
IR spectrometry have to be met. 
LC-full-scan DAD  
 
Group B  Specific requirements for absorption in 
UV spectrometry have to be met 
LC –fluorescence Group B Only for molecules that exhibit native 
fluorescence and to molecules 
that exhibit fluorescence after either 
transformation or 
derivatisation 
2-D TLC – full-scan 
UV/VIS 
Group B Two-dimensional HPTLC and co-
chromatography are mandatory 
GC-Electron capture 
detection 
Group B Only if two columns of different 
polarity are used 
LC-immunogram Group B Only if at least two different 
chromatographic systems or a 
second, independent detection method 
are used 
LC-UV/VIS (single 
wavelength) 
Group B Only if at least two different 
chromatographic systems or second, 
independent detection method are used. 
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1.3 Analytical Approaches to Macrolide and Aminoglycoside 
Determination 
The aminoglycosides are a group of compounds that are polar, resistant to 
acids, bases and heat and are not extensively bound to proteins
7
. Although some work 
has been carried out to date on this class of compounds there is still huge potential for 
further research. The macrolides are more hydrophobic molecules and are unstable in 
acid
5
. In an excellent review paper by Stead
2
 in 2000 the current methodologies for 
the analysis of aminoglycosides and macrolides are discussed with focus on both 
qualitative and quantitative methods. This literature review will focus especially on 
the current methodologies post 2000 and in particular for the analysis of 
aminoglycosides and macrolides used in veterinary medicine with reference to the 
European legislation Commission Decision 2002/657/EC
6
. 
A lot of the research (Table 1.5) focuses on bovine tissue and in many cases 
does not cover the diverse range of this antibiotic family. There are many factors 
which need to be addressed in order to develop a method which would be capable of 
analysing the range compounds to the required level e.g. pH, extraction methods and 
mobile phase. Over the next few chapters this will be explored in more detail. 
Confirmatory methods must fall within strict criteria in order to comply with 
legislation as discussed in section 1.2. Detection of low levels of aminoglycoside 
residues in animal products by mass spectrometry is one of the more difficult 
analytical problems
12
. For example, for group B compounds there must be at least 3 
identification points which means a parent mass and two daughter products are 
necessary. In a validated method by Heller
12
 et al., the confirmation of gentamicin and 
neomycin by ESI/ ion trap tandem mass spectrometry at 30 pg/µl in milk was 
presented.  
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Posyniak
13
 et al., presents a HPLC method with fluorescence detection limits 
of quantitation for gentamicin and neomycin of 0.1 and 20 pg/µl respectively, in 
muscle, liver or kidney tissue.  The determination of gentamicin in hospital 
wastewater by LC-MS/MS is described in a paper by Loffler
14
 et al., with limits of 
quantification of 0.2 pg/µl. Bruijnsvoort
15
 et al., presents an LC/MS/MS method with 
a limit of quantitation for streptomycin of 2 pg/µl in honey and 10 pg/µl in milk and 
for dihydrostreptomycin these limits were a factor of 2 lower.  A recent publication by 
Kaufmann
16
 et al., described a method capable of reaching levels between 15 and 40 
pg/µl for 11 aminoglycosides in a range of matrices including pork muscle and veal 
liver with run times of 15 minutes. 
For the macrolides a number of sensitive methods have been reported. 
Detection limits of 0.4 ppb for erythromycin and 4ppb for tylosin in bovine meat by 
enzyme-linked immunosorbent assay (ELISA) are possible
17
. Tylosin and lincomycin 
residues in honey by LC-MS/MS gave detection limits of 5 and 2 ppb for lincomycin 
and tylosin, respectively
18
. Detection limits of 50 ppb for josamycin, kitamycin, 
microsamicin, spiramycin and tylosin were reported using HPLC
19
.  A multi-residue 
method for seven macrolides including spiramycin, erythromycin and tylosin in 
poultry muscle by LC-MS achieved detection limits in the range 1-20 ppb
20
.  
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Table 1.5 Summary of Techniques for macrolide compounds  
Reference Compound 
analysed 
Sample Sample 
clean-up 
Recovery (%) Method Range Sensitivity 
 
Granelli
21
 et al., 
2007 
Tylosin & 
spiramycin 
Muscle & kidney 
various species 
Solvent 
extraction 
80-86 from 
porcine muscle 
LC-
MS/MS 
0 –4MRL 0.5 MRL  
 
Xu
22
 et al., 2007 Eight 
macrolides 
Honey SPE 60 – 130 LC-
MS/MS 
2-40 ppb 0.2 ppb 
Civitareale
23
 et al. 
2004 
Spiramycin, 
Tylosin 
Animal feed SPE –CN 
columns 
99-74 spiramycin 
81-53  tylosin 
HPLC-
UV/DAD 
--- 176 ppb 
Spiramycin 
118 ppb Tylosin 
Cherlet
24
 et al. 
2002 
Tylosin Porcine tissue  SCX- SPE  --- LC-
MS/MS 
50 – 200 ppb 0.2 – 0.8ppb 
 
Codony
20
 et al. 
2002 
Seven 
macrolides 
Poultry muscle Cation 
exchange SPE 
56-93 LC-MS Up to 1000 
ppb 
4 – 35 ppb 
 
Berrada
25
 et al., 
2007 
Seven 
macrolides 
Bovine Liver and 
kidney 
SPE 40 – 93 LC-DAD 
& LCMS 
50-1000 µg/kg CCα 60 – 1005  
µg/kg 
Gracia-Mayor
26
et 
al., 2006 
Seven 
macrolides 
Ovine milk NaOH and 
ethyl acetate 
55 –77 LC-
UV/DAD 
--- 24 –72 ppb 
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Table 1.6 Summary of Techniques for aminoglycoside compounds  
Reference Compound 
analysed 
Sample Sample clean-up Recovery 
(%) 
Method Range Sensitivity 
Bogialli
27
et 
al., 2005 
Nine AMGs 
(incl. 
streptomycin & 
apramycin) 
Bovine milk  Off-line hot water 
extraction 
79 –92 LC-
MS/MS 
0.2 – 400 ppb LOQ 2 ppb –  13 ppb 
Bruijnsvoort
1
5
 et al., 2004 
Streptomycin & 
DHstrep 
Bovine milk 
Honey 
LLE 
SPE 
81- 102 LC-
MS/MS 
50- 800 µg/kg 
(milk) 
LOQ 1-10 µg/kg 
 
Hornish
28
et 
al., 1998 
Spectinomycin Bovine 
kidney, liver, 
muscle and fat 
SPE 80 LC-
MS/MS 
0.1 – 10 mg/g LOQ 0.1 mg/g 
Carson
29
 et 
al., 1998 
Spectinomycin Bovine milk Ion-pair SPE 69- 93 LC-
MS/MS 
0.1-5 mg/mL LOQ 0.05- 0.1 
mg/mL 
Hammel
30
 et 
al., 2008 
3 AMGs,  
7macrolides 
Honey Liquid -liquid 
extraction 
28-214 amgs. 
28–104 
macrolides 
LC-
MS/MS 
Matrix matched 6 
point calibration 
LOD 20 µg/kg 
McLaughlin
3
1
 et al., 1994 
6 AMGs Bovine 
Kidney 
Matrix solid 
phase dispersion 
--- LC-
MS/MS 
--- --- 
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1.4 Macrolides and Aminoglycosides 
  
The most commonly used aminoglycosides in veterinary medicine in Europe are 
gentamicin
32
 along with neomycin, streptomycin and dihydrostreptomycin. The most 
commonly used macrolides are erythromycin and tylosin
32
.  The use of aminoglycosides 
and macrolides for their growth promotion properties is banned in the EU. Therefore it is 
impossible to rule out the use of other members of this family e.g. spectinomycin and 
kanamycin which both have an established MRL.   
Much of the research to date has focused on individual members of the family for 
e.g. a publication by Loffler
14
 et al., presents an analytical method for the determination 
of gentamicin in hospital wastewater by LC-MS/MS using kanamycin as an internal 
standard. In another method gentamicin and neomycin in animal tissue were investigated 
in terms of sample preparation
13
.    
Some authors have investigated the determination of a number of analytes, from 
the one family, in the same assay in bovine tissues by ion-pair LC-MS
31
. These analytes 
include spectinomycin, hygromycin B, streptomycin and dihydrostreptomycin This multi-
residue method for the confirmation of aminoglycosides in bovine tissue used matrix 
solid-phase extraction (SPE) to isolate the aminoglycosides. It is clear that while 
researchers are developing useful methods for aminoglycosides and macrolides (Tables 
1.5 and 1.6) there is a need for suitable multi-analyte confirmatory methods that would 
include the compounds with both established and provisional MRL values in the same 
assay. 
Due to the safety issues surrounding these compounds, and the MRL‟s associated 
with them, there is huge pressure on the analytical assays to be extremely sensitive. The 
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trend has been to see more and more LC-MS methods being reported for this area of 
research. The review by Stead
2
 investigated both qualitative and quantitative 
methodologies for the analysis of aminoglycosides. In that paper, the techniques most 
commonly used for the aminoglycosides were automated immunoassays for screening of 
aminoglycosides and HPLC with MS detection for quantitation. Limits of detection were 
of the order 50 ppb for streptomycin in milk by HPLC
33
 and 70 ppb for spectinomycin in 
tissue extract by HPLC
34
. 
1.5 Aims and Objectives 
This chapter has presented a thorough background into the chemistry of these two 
groups of antibiotics and the legislation covering their permitted use in animal products. 
Various methods in the literature have been tabulated to show the current research that 
has been carried out and summarises the extraction methods employed together with the 
individual anlaytes and the techniques employed together with their sensitivity.   While it 
is clear from the above that some work on these compounds has been carried out, a 
suitable confirmatory method that would cover the compounds with established MRL‟s 
(Table 1.2) and provisional MRL‟s (Table 1.3) would be very useful. This forms the basis 
of this research. In summary, while it is apparent that low LOD values can be achieved, 
this can vary widely depending on the analyte being determined, the sample preparation, 
the technique used and the sample matrix. Another issue is that it can be difficult to reach 
the required sensitivity levels for all the analytes within one run. 
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Chapter 2: Sample Preparation used in the analysis of the 
Aminoglycoside and Macrolide antibiotics and presentation of 
an Experiment to extract Aminoglycoside and Macrolide 
antibiotics from Bovine Muscle. 
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2.1 Introduction 
 
 The analysis of the aminoglycosides and macrolides in animal tissues is made 
very challenging due to a number of important factors. The matrices involved are 
generally difficult by virtue of the fact that they are complex in many ways. Animal 
tissues like muscle and liver contain many possible interfering substances such as 
proteins and fats that need to be removed or reduced as much as possible without 
affecting the residues of interest, in this case the antibiotics. Another challenge, in sample 
preparation of these antibiotics, is that they can be present in very small quantities and 
there may be more than just one compound of interest present to be determined. These 
challenges are of utmost importance when developing a suitable extraction procedure. 
 
2.2 Extraction and Clean-up Methods in the Literature 
The target tissues specified by legislation that have to be monitored are such that 
extraction and clean up methods play a very important role in the overall analysis. 
Biological matrices like muscle and liver contain many possible interfering substances 
that need to be removed selectively.  
The usual techniques employed for extraction and clean up of antibiotics from 
biological matrices include protein precipitation, liquid-liquid extraction (LLE) and solid-
phase extraction (SPE)
1
. A good source of information on the methodologies for 
extraction and clean up of antibiotics in bio matrices can be found in “Chemical Analysis 
for Antibiotics used in Agriculture”2. An overview of different antibiotics and their clean-
up and extraction from various matrices is given. Another reference for information on 
methodologies for extraction and clean up of antibiotics in food matrices has been 
published by Buldini
3
 et al., The determination of the macrolides from some matrices has 
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been reported to be possible with no sample clean-up. In one report, honey samples were 
diluted and injected directly into the LC-MS/MS system without additional steps such as 
solid-phase extraction or liquid-liquid extraction
4
. Normally, the issues of matrix 
interference and blocking of columns or injectors in systems necessitate some sample 
preparation prior to analysis. 
2.2.1 Protein precipitation 
Deproteinisation is a commonly method for the extraction/ clean-up step of 
sample preparation of antibiotics in bio matrices. It is used where removal of 
interferences is necessary whilst retaining good recoveries of the analytes of interest. An 
advantage of protein precipitation is that it is a relatively simple and inexpensive off-line 
procedure. An example of the advantages of deproteinisation was shown in Kowalski
5
 et 
al., where the determination of streptomycin in eggs was achieved using acetonitrile as 
the deproteinisation solution. A detection limit of 0.12 µg/g and recovery levels of ~72% 
have been reported
5
. This method demonstrated the effectiveness of deproteinisation 
using an organic solvent, as eggs are an especially difficult matrix to work with due to 
their proteinaceous nature. Acids such as trichloroacetic acid or perchloric acid
6,7
 can also 
be used for protein precipitation prior to analysis of food samples.  
2.2.2 Liquid-liquid extraction 
Liquid-liquid extraction (LLE) has been exploited as an extraction procedure for 
aminoglycosides and macrolides from complex matrices. In a method published on 
determination of the aminoglycosides streptomycin and dihydrostreptomycin, milk 
samples were prepared using LLE
8
.  The method was validated over a linear range from 
50 to 800 µg kg
-1
. The recoveries were found to be slightly low at 60% due to matrix 
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suppression. A number of papers have reported extraction with acetonitrile prior to clean-
up of the extracts by LLE with hexane
9,10,11,12
. In some cases, this procedure was 
followed by solid-phase extraction. 
Supported liquid membrane (SLM) extraction and/or enrichment is similar to 
liquid–liquid extraction and dialysis combined13. In SLM, an organic liquid is embedded 
in small pores of a polymer support and is held there by capillary forces. If the organic 
liquid is immiscible with the aqueous feed and strip streams, SLM can be used to separate 
the two aqueous phases. It may also contain an extractant, a diluent (which is generally an 
inert organic solvent to adjust viscosity) and sometimes also a modifier to avoid the 
formation of an emulsion
14
.  One of the advantages of SLM is that the relatively small 
volume of organic components in the membrane and simultaneous extraction and re-
extraction in one technological step results in high separation factors, easy scale-up, 
lower energy requirements and thus lower overall running costs
14
. 
The use of SLM has been reported for extraction of macrolides from kidney and 
liver tissue
15
. The macrolides were detected following extraction at concentration levels 
of 0.01, 0.03 and 0.08 µg kg
-1
 for tylosin tartrate, erythromycin and spiramycin, 
respectively. A 1-decanol/undecane (1:1) liquid membrane at pHs of 9 and 3 for donor 
and acceptor, respectively was utilised. SLM was also used to extract a mixture of 
aminoglycoside compounds - neomycin, gentamicin and streptomycin - from cow's milk 
and urine
16
 using the same liquid membrane as above.  
2.2.3 Solid Phase extraction 
Solid phase extraction (SPE) involves liquid–solid partition, where the extracting 
phase is a solid sorbent. This technique and versions thereof, have been used extensively 
to extract and concentrate trace organic materials from food samples
17
. Wide choices of 
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sorbents are available which rely on different mechanisms for extraction/retention of 
analytes. While there are drawbacks associated with SPE such as the importance of 
packing uniformity to avoid poor efficiency, this technique can be used to extract 
veterinary residues from even the most challenging matrices such as shrimp
18
.  
The aminoglycosides are very hydrophilic compounds hence, prior to say LC 
analysis, a clean up with for e.g. SPE is necessary with complex matrices like tissues or 
honey
8
. SPE uses most of the phases and separation mechanisms that are available for 
HPLC. Medina et al.,
19
 developed a method for the extraction of Hygromycin B from 
animal plasma and serum followed by detection by semi- quantitative TLC. The solid-
phase extraction system used “clean screen DAU resin” which is co-polymeric bonded 
silica with hydrophobic and ionic functions. Various effects on the recovery of 
Hygromycin B were studied for e.g. the combined effects of amount of resin, sample 
volume and elution volume used. The acidified column packing was conditioned with 5% 
diethylamine-methanol followed by methanol and then de-ionised water. The pH was 
then adjusted to pH 6.0 with potassium phosphate buffer. The acidified samples were 
then loaded onto the columns followed by a rinse step with water and finally eluted with 
diethylamine-methanol. 
Recently, Bruijnsvoort et al.,
8
 found that a C18 packing in the SPE cartridge was 
preferable to a cation-exchange packing material. This method found the extraction of 
streptomycin and dihydrostreoptomycin from honey and milk with methanol from a C18 
cartridge to be preferable. Variation was seen between different SPE brands with the 
Baker 200 mg C18 cartridge performing. Recoveries of >80% were achieved. Kaufmann 
et al.,
20
 were able to extract 11 aminoglycosides from fish, pork and liver samples using a 
low-pH extraction with trichloroacetic acid followed by SPE. The cartridge material was 
a weak cation-exchanger. Babin et al.,
21
exploited on-line SPE for the extraction of three 
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aminoglycosides from veal tissues. This automated clean-up and analysis system enabled 
the analysis of 24 veal samples in half a day with recoveries of 51-76%.  
Six macrolides were extracted from eggs, honey and milk using initial clean-up 
with acetonitrile or phosphate buffer (pH 8.0) followed by SPE
22
. Across all macrolides 
and all spiked concentration levels, recoveries were greater than 88%. Berrada et a.,l
23
 
used the same Oasis HLB cartridges, as employed by Wang
12
, for extraction of seven 
macrolides from liver and kidney samples. Recoveries were > 67% for most of the 
antibiotics studied at the 200 µg kg
-1
 spiking level. Recoveries of 74-107% were obtained 
for six macrolides in animal feeds using the Oasis HLB cartridges again and an extra 
back extraction step
24
. Two macrolides were extracted using silica SPE cartridges but 
recovery was poor – estimated to be 40-55%25. Eight macrolides were extracted from 
honey by SPE with recoveries of 60-130%
26
. Carson reviewed the use of ion-pair SPE 
and discussed its potential application to multiclass multiresidue analysis
27
. 
2.2.4 Matrix Solid-phase Dispersion 
Matrix solid-phase dispersion (MSPD) is a sample pre-treatment procedure that is 
increasingly used for extracting/purifying analytes from a variety of solid and semi-solid 
foodstuffs. MSPD is primarily used because of the possibility of performing extraction 
and clean-up in one step (illustrated in Figure 2.1), leading to a faster overall analysis 
time and lower consumption of solvents
28
. The aminoglycosides have been extracted 
using MSPD in the literature. Nine aminoglycosides were extracted from milk with 
heated water (70 ºC) followed by LC–MS/MS. After acidification and filtration, 0.2 mL 
of the aqueous extract was injected into the LC column. Recoveries ranged between 70 
and 92%. The LOQ values for this method were between 2 and 13 g L
-1,29
. An extraction 
method for the macrolides based on the MSPD technique with hot water as extractant 
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proved to be robust as matrix effects, even though present, did not significantly affect the 
accuracy of the method. After dispersing samples of milk and yogurt on sand, target 
compounds were eluted from the MSPD column by passing through it 5mL of water 
acidified with 30 mmol L
−1
 formic acid and heated at 70
o
C. After pH adjustment and 
filtration, a volume of 200 µl of the aqueous extract was directly injected onto the LC 
column. Hot water was found to be an efficient extracting medium, given absolute 
recoveries of the analytes from milk and yogurt were 68–86% and 82–96%, 
respectively
30
. 
 
Figure 2.1 Schematic of a typical MSPD extraction procedure, Bogialli et al.,
30
 
 
2.2.5 Pressurised liquid extraction 
In the case of a number of complex sample matrices, pressurised liquid extraction 
(PLE) was employed
31, 32, 33
 using an automated Dionex ASE 200 system. PLE is an 
accelerated liquid extraction (ASE) procedure, whereby increased temperature 
accelerates the extraction kinetics, and elevated pressure keeps the solvent below its 
boiling point. ASE is reported to use the same aqueous and organic solvents as traditional 
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extraction methods, and the method uses the solvents more efficiently. The extracts are 
completely transferred for further solid-phase extraction, typically using Oasis HLB 
sorbent or equivalent. The advantage of using PLE is the online capability and it was 
found to compare well against ultrasonic solvent extraction for extraction of macrolides
38
. 
In summary, there are many different ways to extract aminoglycosides and macrolides 
from food matrices. However, sometimes compromises are required. For example, for 
screening methods time and cost issues are more important than the removal of all matrix 
interferences so that a simple extraction system might be more suitable than a more 
complex extraction with higher recoveries. The number and type of analytes the method 
must selectively extract is also of consideration. 
 
2.3 Introduction for Experiment to extract Aminoglycoside and 
Macrolide antibiotics from Bovine Muscle. 
The Central Meat Control laboratory (CMCL) is the National Reference 
Laboratory (NRL) for these two groups. The laboratory is required to monitor these 
residues in accordance with the legislation, as discussed in Chapter 1, in a variety of 
animal tissues such as muscle and kidney. The sample preparation for these matrices is 
difficult as there are many possible interferences that need to be reduced/ removed prior 
to analysis, thus a good sample preparation technique that will remove interferences 
while retaining the analytes of interest is desirable. 
2.4 Aim            
                The aim of this sample preparation experiment was to investigate various solid 
phase extraction cartridges in terms of their recovery and selectivity for a mixture of 
aminoglycoside and macrolide antibiotics. 
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2.5  Materials and Methods 
2.5.1 Reagents 
The following antibiotics, tobramycin (89549), apramycin sulfate (A2024), 
kanamycin sulfate (60616), dihydrostreptomycin sesquisulfate (37386), spectinomycin 
dihydrochloride pentahydrate (85555), streptomycin sulfate (2158X), spiramycin mixture 
of I, II and III (S-9132), tylosin tartrate (T-6134), roxithromycin (R4393), lincomycin 
(62143) and paromomycin sulfate (76261) were purchased from Sigma-Aldrich 
Corporation. 
The following HPLC grade solvents, methanol, acetonitrile and ultra-pure water 
were purchased from Fisher Scientific. Negative (macrolide and aminoglycoside free) 
bovine muscle was sourced from Abbotstown farm and screened in-house using a 
microbiological 6-plate assay to ensure negativity, then homogenised and divided into 5g 
individual portions. Heptafluorobutyric acid (HFBA) was purchased from Sigma-Aldrich 
Corporation. 
Various Waters Oasis
®
 solid phase extraction cartridges used were WCX, WAX, 
MCX, MAX and HLB that were all purchaed from Waters Chromatography, Ireland. 
Varian bond Elut LRC-SCX 500mg part number 12113039, Phenomenex Strata X and 
Varian bond Elut C18 200mg/ 3mL part number 35402 were purchased from JVA 
Analytical. 
 
2.5.2 Intrumentation 
2.5.2.1 UPLC-MS/MS Instrumentation 
The Ultra Performance Liquid Chromatography system (UPLC) was a Waters 
Acquity UPLC
®
 system with a 2.1 x 50mm (1.7µm) C18 Acquity UPLC
®
 BEH column, 
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Acquity Sample Organiser, In-line degasser AF, Column Manager and Heater/ Cooler, 
Binary Solvent Manager and Sample Manager. Data was processed using Waters 
Masslynx
TM
 software. 
The mass spectrometer used was a Waters Quattro Premier
TM
 XE tandem quadrupole 
mass spectrometer utilising T-wave
TM
 collision cell, multi-mode ionisation and rapid 
polarity switching technologies. 
 
2.5.2.2 Extraction Equipment 
The extraction equipment used consisted of a REAX 2 overhead shaker together 
with a Heidolph test tube shaker, a Techne sample concentrator FSC 400D with Techne 
Dri-block heater DB-3 with 127mm needles and insert blocks were purchased from 
Lennox Chemicals Ltd.. The vacuum chamber was a VacElut 20 purchased from JVA 
Analytical and the Laboport vacuum/ pressure diaphram self drying pump was purchased 
from Carl Stuart Limited. 
 
2.5.3 Preparation of Standards and Samples 
2.5.3.1 Standard Solutions 
Stock solutions (500µg/mL) of spiramycin, tobramycin, apramycin, kanamycin, 
dihydrostreptomycin, lincomycin, spectinomycin, tylosin, and roxithromycin were 
prepared in methanol. Stock solutions (500µg/mL) of streptomycin and paromomycin 
were prepared in ultra-pure water. Mixed standard solutions at 100ng/mL, 200ng/mL, 
300ng/mL, 500ng/mL and 1000ng/mL were diluted from stocks in water. All standards 
were prepared in polypropylene volumetric units and stored in polypropylene amber 
storage jars at 4ºC. 
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2.5.3.2 Matrix Samples 
2g muscle samples were homogenised, weighed and placed in 50mL 
polypropylene centrifuge tubes. Each tube was labelled with weight and date and stored 
at -20ºC until used. Matrix samples were spiked at appropriate levels using mixed 
standard solutions immediately prior to extraction. 
Samples were then de-proteinised by adding 10mL of either 5% trichloroacetic 
acid or 5% ammonium hydroxide and placed on a shaker for 10 minutes. The samples 
were then centrifuged at 10,000rpm for 10 minutes and a 3mL aliquot was transferred to 
the solid phase extraction cartridge. 
 
2.5.4 Assay Conditions 
 
2.5.4.1 Extraction/ Clean-up Protocol 
 
 Cartridges were conditioned with 3mL methanol followed by an equilibration step 
with 3mL water. The 3mL sample was loaded onto the cartridge and the cartridge was 
washed with 3mL water. The analytes were then eluted in either 3mL methanol or 3mL 
of a 2% formic acid solution in methanol. This eluate was evaporated under nitrogen on a 
heating block set at ~45ºC and then re-constituted in 300l water. 
 
2.5.4.2 UPLC  Method 
 
Gradient elution was used with solvent A (ultra-pure water with 10mM HFBA) 
and solvent B (100% methanol or 100% acetonitrile, where indicated) as follows: T0 
90/10, T0.5 90/10, T1.0 50/50, T2.5 50/50 T4.0 40/60 T5.0 40/60, T5.5 90/10, T6.0 90/10. The 
system was conditioned with 15% solvent B for 1 hour prior to use on each day or until a 
delta pressure of <40psi was observed on the Solvent Manager. The mobile phase was 
degassed and filtered by passing through a 0.45µm pore size membrane filter (Milipore, 
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Milford, MA, USA) prior to use and further degassed with the in-line degasser. The flow 
rate was 0.450 mL min
-1
. All injections were performed on column at temperature of 
35ºC with injection volumes of 10 to 20µl as indicated. 
 
2.5.4.3 MS Conditions 
 
Tuning for all analytes was carried out for the mass spectrometer with the 
optimised conditions as follows: Capillary (kV) 3.5, Extractor (V) 4.00, RF lens (V) 0.4, 
Source Temperature (ºC) 120, Desolvation Temperature (ºC) 350, Cone Gas Flow (L/Hr) 
200, Desolvation Gas Flow (L/Hr) 900, Ion Energy MS1 0.8 and Ion Energy MS2 1.0 
Table 2.1: Parent and Daughter Ions with optimised collision and cone 
voltages 
Analytes Parent Ion 
(M)+ 
Daughter 
Ions 
Collision 
(eV) 
Cone 
(V) 
Tylosin 916.5 174.2 & 101.4 40 & 45 50 
Roxithromycin 837.4 158.4 & 679.5 30 & 20 30 
Streptomycin 582.1 263.2 & 176.1 35 & 40 60 
Dihydrostreptomycin 584.1 246.2 & 263.1 35 & 30 50 
Paromomycin 616.2 163.2 & 203.2 40 & 40 45 
Spiramycin 843.5 174.2 & 101.2 40 & 40 40 
Spectinomycin 333.2 98.1 & 116.1 30 & 25 55 
Lincomycin 407.2 126.4 & 359.2 30 & 20 40 
Kanamycin 485.2 163.0 & 205.2 30 & 30 30 
Apramycin 540.2 217.2 & 378.2 30 & 20 55 
Tobramycin 468.2 163.2 & 205.3 25 & 25 30 
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2.6  Results and Discussion 
 The macrolides and aminoglycosides are basic analytes with known pkA‟s 
ranging from 5.4 for apramycin (one of four protons) to 9.5 for roxithromycin. During 
this experiment a number of different solid phase extraction cartridges were tested. A 
study using the waters Oasis

 range of products (see Figure 2.2) was carried out to assess 
potential for extracting the analytes form bovine muscle samples.  
The following cartridges were compared:  
 HLB: Hydrophilic- lipophilic sorbent for all compounds.  
 MCX: A mixed-mode Cation exchange and reverse-phase sorbent suitable for 
bases, high selectivity for basic compounds. 
 MAX: A mixed-mode Anion exchange and reverse-phase sorbent suitable for 
acids, high selectivity for acidic compounds. 
 WCX: A mixed-mode Cation exchange and reverse-phase sorbent with a high 
selectivity for strong bases. 
 WAX: A mixed-mode Anion exchange and reverse-phase sorbent with a high 
selectivity for strong acids. 
 
 
 
 
 
 
Figure 2.2: Waters Oasis
®
 Solid-Phase Extraction Cartridges
34 
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2.6.1 Waters Oasis® 2x4 method 
This experiment used a mixture of standards that were prepared at the maximum 
residue levels and a number of 2g samples of muscle were spiked with this mixture. A 
weak acid, 10mL % trichloroacetic acid, and an alternative weak base, 5% ammonium 
hydroxide were then added to the samples to de-proteinise. Using the protocols set out in 
Figure 3.2 below, elutes 1 and 2 were collected and analysed by UPLC-MS/MS. 
Figure 2.3: Adapted Waters Oasis
®
 2x4 Method
34
 
  
For Bases: 
pKa 2-10 
Use Oasis
®
 MCX 
For Strong Acids 
pKa <1.0 
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®
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®
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Prepare Sample 
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Wash: Water 
 
Elute 1: 100% MeOH 
 
Elute 2: 2% Formic Acid 
in MeOH 
Protocol 2 
Prepare Sample 
 
Condition/Equilibrate 
Load Sample 
 
Wash: Water 
 
Elute 1: 100% MeOH 
 
Elute 2: 5% TCA 
 
Protocol 1 
For Acids 
pKa 2-8 
Use Oasis
®
 MAX 
Bases 
Strong  
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Strong  
Bases 
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The macrolides and aminoglycosides are basic analytes and as expected the best results 
were seen for the MCX and the WCX cartridges with good responses seen for seven of 
the 11 analytes in Elute 2 on the MCX cartridge. This elute was in 5% TCA and the de-
proteinisation method used was 5% trichloroacetic acid (see Figure 2.3). 
 
Figure 2.4: TIC data for elution of 7 aminoglycosides and macrolides. X axis time, y 
axis response. UPLC conditions: Solvent A 10mM HFBA, Solvent B Acetonitrile. 
Gradient, Initial 90% A, 4.5min 50% A,  8.5min 30% A, 9.5min 90% A, 10.5min 
90% A. Flow rate: 0.3ml/min. Peaks a to g, roxithromycin, tilmicosin, 
paromomycin, tobramycin, apramycin, kanamycin and lincomycin. 
 
 
 
 
 
a 
b 
c 
d 
g 
f 
e 
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2.6.2 Waters HLB Cartridge and Phenomenex Strata X 
 The waters HLB 6cc 200mg Cartridges and the Phenomenex  Strata X 6cc 200mg 
Cartridges were also compared. They were chosen for their ability to extract across a 
wide pKa range. Two extraction solutions were chosen, 50:50 MeOH:water and 50:50 
ACN:water.  A number of 2 gram samples were taken and spiked at the MRL level for 11 
analytes of various aminoglycosides and macrolides and the extraction method below 
was performed. 
Waters HLB and Strata X extraction method 
• Condition with 5mL MeOH and equilibrate with 5mL H2O 
• Load 5mL sample.    Collect 
• Wash with 5mL 10% MeOH.   Collect 
• Elute with 5mL 100% MeOH.   Collect  
• Evaporate to dryness under nitrogen and re-constitute in 1mL H2O 
 
 Results proved disappointing with various problems encountered such as pressure 
problems on system and column, the sample cone in the mass spectrometer tended to get 
dirty very quickly which meant that it needed cleaning regularly. This is a problem with 
muscle samples and their clean up as discussed in section 2.2. There was also a difficulty 
resolving eluting compounds of similar molecular weights and a difficulty in finding an 
extraction method to reduce matrix effects while retaining extraction of all the 
compounds. The HLB results were better in terms of the number of analytes recovered 
(Figure 2.5). Comparing the two extraction solvents the 50:50 acetonitrile:water mix gave 
higher recoveries e.g. lincomycin when compared with a standard directly analysed gave 
a recovery of ~20% in the acetonitrile mix compared to only about 5% in the methanol 
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mix. The overall results for the study however were poor with few compounds extracting 
with satisfactory recoveries.  
 
Figure 2.5: TIC data for elution of 5 aminoglycosides and macrolides. X axis time, y 
axis response. UPLC conditions: Solvent A 10mM HFBA, Solvent B Acetonitrile. 
Gradient, Initial 90% A, 4.5min 50% A,  8.5min 30% A, 9.5min 90% A, 10.5min 
90% A. Flow rate: 0.3ml/min. HLB Elute at MRL level. Peaks a to e: 
Roxithromycin, tylosin, tilmicosin, spiramycin and lincomycin. 
 
2.7 Conclusion 
  There are a number of ways to extract these compounds from complex matrices 
like animal tissue. Protein precipitation is relatively cheap and fast enabling clean up to 
of samples where speed is critical for e.g. in keeping turn-around times down. Liquid-
liquid extraction and supported liquid membrane are useful for extracting mixtures of the 
aminoglucosides and macrolides at low levels however the recoveries were poor for 
analysis in milk. Overall either of these techniques would have the advantage of being 
easy to scale up and cheap to run. For an extraction experiment to look at a mixture of 
a 
b 
c 
d 
e 
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aminoglycosides and macrolides in tissue samples the technique that offers the most 
options is SPE. In terms of choice of sorbent, the ability to concentrate trace materials 
from complex matrices, automation and good recoveries, SPE is the most versatile.    
 A significant amount of work was carried out in order to develop and optimise the 
extraction of these two groups of antibiotics from very difficult matrices such as bovine 
muscle. The current techniques in the literature were thoroughly researched to look at the 
various options prior to carrying out many trials with various solid-phase extraction 
cartridges. The sample preparation for these analytes is a critical step for any method that 
intends to confirm their quantity and presence and thus a number of different solid-phase 
extraction techniques have been presented here which could be investigated further to 
look at optimising their use for these groups.  
 The sample preparation technique using the Oasis
®
 HLB cartridge resulted in a 
greater number of analytes recovered (Figure 2.5) when compared to the Phenomenex 
Strata X cartridge. For the Oasis
®
 2x4 method the MCX cartridge resulted in the greatest 
number of analytes eluting. This was expected as the MCX cartridge is recommended 
when trying to extract bases like the aminoglycosides and macrolides. 
  Comparing extraction solvents, for the Oasis
®
 HLB cartridge, the 50:50 
acetonitrile:water mix gave higher recoveries e.g. lincomycin when compared with a 
standard directly analysed gave a recovery of ~20% in the acetonitrile mix compared to 
only about 5% in the methanol mix.  
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Chapter 3: Methods of analysis for the Aminoglycoside and 
Macrolide antibiotics. 
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3.1  Introduction 
 
The presence of aminoglycoside and macrolide residues in animal products must be 
monitored according to legislation set out in chapter 1. Due to the safety issues 
surrounding these compounds, and the MRL‟s associated with them, there is huge 
pressure on the analytical assays to be extremely sensitive. The trend has been to see 
more and more LC-MS methods being reported for this area of research. There are 
however many methods, both chemical and biological, used to determine the presence 
(screening/ qualitative assays) and amount (quantitative assays) of these residues in 
animal tissues, and these will be discussed here. 
 
 
3.2 Screening Methods-Chemical  
 
 
3.2.1 Thin Layer Chromatography 
 
Thin layer chromatography (TLC) is one of the most popular and widely used 
separation techniques due to a number of factors including ease of use, wide applications, 
good sensitivity, speed and low cost
1
. Chromatography is a method of separating a 
mixture into its various components. The mobile phase carries the sample through the 
fixed stationary phase and based on the heterogeneous equilibrium between these two 
phases the components of the sample are separated. The stationary phase can be either a 
solid or liquid and the mobile phase a gas or a liquid. Chromatography is often defined by 
these as liquid-solid, liquid-liquid, gas-solid or gas-liquid
1
.  
The measurement parameter in any form of chromatography is the distribution 
coefficient (k) of a substance between the two phases. k is dependent on the temperature 
and concentration of the solute (Touchstone 1983). 
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Equation 3.1: 
DistributionCoefficient(k)= 
Phase Mobile ofper Unit  Solute ofAmount 
Phase Stationary ofper Unit  Solute ofAmount 
 
 
In a review by Stead
2
, the use of TLC as a qualitative method for the 
aminoglycosides has been well documented. The separation of aminoglycosides by 
normal phase and reverse phase TLC is presented in a paper by Bhushan et al.,
3
 where 
streptomycin, kanamycin, gentamicin and tobramycin were determined with detection 
limits of 0.4 – 0.6 g possible. The macrolides have also been assayed by TLC4. 
 
3.2.2 Capillary Electrophoresis 
 
Capillary electrophoresis (CE) describes a family of techniques used to separate a 
variety of compounds. These analyses, all driven by an electric field, are performed in 
narrow tubes and can result in the rapid separation of many hundreds of different 
compounds. The versatility and number of ways that CE can be used means that almost 
all molecules and even whole organisms can be separated using this powerful method. 
There are a number of different ways of performing CE separations. This makes 
the technique especially useful when optimised for a separation of interest in e.g. 
ensuring purity during manufacture, or diagnosing illness in a hospital. Separations 
driven by electrophoresis also have a novel separating mechanism. This makes them 
useful in situations where other liquid phase separation techniques are limited or 
impractical. Some of the advantages of capillary electrophoresis include very high 
efficiencies (meaning hundreds of components can be separated at the same time), small 
sample size, automation, and it is quantitative. However, one of the drawbacks associated 
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with the use of CE for determining trace levels of residues is that it is sometimes not 
sensitive enough due to the lower sample injection volumes required and short optical 
path-length for on-capillary detection
5
.  
The aminoglycosides are difficult to analyse by capillary electrophoresis due to 
the problems in detecting these compounds using spectrophotometric means as many of 
these compounds lack chromophores
6
. Hence, initial work saw the aminoglycosides first 
detected by CE using indirect UV detection with imidazole as the background electrolyte 
under low pH and reversed polarity conditions
7
.  The problems encountered were mainly 
in the difficulty separating closely related compounds. Subsequent work by Flurer et al.,
6
 
showed that borate buffers could be used to allow direct detection of the aminoglycosides 
by UV detection at 195 nm. Based on the formation of negatively charged complexes 
between the hydroxyl moieties minor differences were emphasized between compounds 
and separation of twelve aminoglycosides was possible.  
 Post 2000, work on capillary electrophoresis continued and in a study by Yang et 
al.,
8
 the separation of five aminoglycoside antibiotics used in veterinary medicine with 
electrochemical detection is demonstrated. In this study a copper micro particle-modified 
carbon fiber micro disk array electrode was fabricated. This array showed catalytic 
activity for the aminoglycosides using a separation voltage of 6.2 kV and electrophoresis 
medium of 125 mM NaOH resulting in the separation of the 5 antibiotics within 20 min. 
With linear calibration curves over two orders of magnitude of concentration and 
detection limits of 2µM for all compounds except lincomycin in pharmaceutical 
injectables and further human urine. This investigation showed that with further research 
it would be feasible to determine these antibiotics in other matrices. 
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Capillary zone electrophoresis was successfully applied to separate eight related 
substances of kanamycin and several minor unknowns from the main component
9
. The 
standard curves were linear over the concentration range of 0.007–1.01 mg/mL for the 
main component and 0.003–0.1 mg/mL for the related substances. The limit of 
quantitation was 0.14% (m/m) for the related substances and impurities (S/N=10). A 
review of the use of CE for the aminoglycosides to 2002 found that the choice of detector 
had a great influence on the separations with laser-induced fluorescence (LIF) showing 
the best sensitivity with improvements of up to three orders of magnitude
10
. CE-LIF was 
used by Serrano et al.,
11
 to determine four aminoglycosides in milk. Following 
derivatisation the separation took 20 min and the antibiotics were readily detected at 0.5–
1.5 μg kg-1 levels. A general review of CE methods for antibiotics in a variety of matrices 
including food has been reported
5
.  
 
3.2.3 Optical Biosensor 
Biosensor systems using the surface plasmon resonance (SPR) detection principle 
are recent and provide rapid and reliable results with minimal sample preparation. The 
detection of streptomycin and dihydrostreptomycin residues in milk, honey and meat 
samples using this technique has been reported
12
. The study compared a commercially 
available biosensor kit with a commercially available enzyme immunoassay kit (EIA) 
and a confirmatory HPLC method. The results demonstrated that the biosensor 
technology compared favourably with the immunoassay and HPLC methods. Antibody 
specificity for streptomycin and dihydrostreptomycin was good with < 0.1% cross-
reaction with other aminoglycosides for e.g. neomycin, gentamicin, kanamycin or other 
antimicrobials for e.g. penicillin G and chlortetracycline. The LOD  values were 15, 30, 
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50 and 70 µg kg
-1
 for honey, milk, kidney and muscle respectively. Recoveries ranged 
from 77% to 110% using the biosensor kit. One false positive result for kidney was found 
but no false negatives were found (which is more important in the case of screening 
tests). The Biacore 3000, an optical biosensor with four flow channels was used for the 
detection of five aminoglycosides in reconstituted skimmed milk, in combination with a 
mixture of four specific antibodies. The limits of detection were between 15 and 60 µg 
kg
-1
, which were well below the MRLs, and the total run time between samples was 
7 min
13
. Biosensors have the advantages of simple, fast, sensitive and cost-effective 
detection
14
 thus making them ideal for use in the screening of residues in food.  
A cell-based microbial biosensor for macrolides utilised a luminescence biosensor 
based on the coupling of structural luciferase genes of Vibrio fischeri to the regulatory 
control mechanism of a bacterial erythromycin resistance operon
15
. This system was 
tested on its ability to isolate and characterise picromycin from a Streptomyces species.  
 
3.2.4 Ultraviolet and Visible Spectra 
 
Visible and ultra violet spectra are associated with the transitions between 
electronic energy levels; these transitions are mostly between a bonding or lone-pair 
orbital and an anti-bonding or unfilled non-bonding orbital. When the electrons in the p- 
and d- orbitals are excited which occurs above 200 nm, the spectra are steady and 
informative
16
. In order for a compound to perform with this method it must contain a 
chromophore, this is the part of the compound which contains the electrons responsible 
for the absorption. Generally a conjugated chromophore perform best for e.g. when 
conjugation between two isolated double bonds occurs the energy level of the highest 
occupied orbital is raised and the lowest unoccupied anti-bonding orbital lowered 
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resulting in a strong and easily detected maximum. Aminoglycosides lack chromophores 
and are therefore not amenable to direct UV or fluorescence detection however they may 
be derivatised after separation with UV absorbent or fluorescent agents thus allowing 
analysis with more commonly available spectrometric detectors
2
. 
 
3.2.5 Resonance Rayleigh scattering 
 
Resonance Rayleigh scattering (RRS) is a new analytical method developed in 
recent years that can be used as an alternative to UV-Vis or microbiological assays for 
screening of aminoglycosides. It is based on the aggregation of a conjugated structure in 
biological macromolecules or the ion-association complexes that are formed by the 
reaction between electrostatic and hydrophobic interaction in small molecules
17
.   
A study by Liu et al.,
18
 compared RRS with time consuming microbiological 
assays and lower sensitivity UV-Vis for the aminoglycosides. Results indicated that when 
Evans blue dye and some individual aminoglycosides; kanamycin, gentamicin, 
tobramycin and neomycin react together, an ion-association complex is formed which 
enhances the individual spectrums and a new RRS spectrum is observed. The linear range 
reported was 0.01 – 6.0 ug/mL with a detection limit of 5.2 ng/mL for kanamycin and 
0.02 – 6.0 ug/mL for the other compounds with detection limits for neomycin, 
tobramycin and gentamicin of 5.5, 6.2 and 6.9 ng/mL respectively
18
.  
 This phenomenon has also been reported for pontamine sky blue dye with 
aminoglycosides
19
. While RRS of aminoglycosides has not been used for food samples, it 
has been used in serum and therefore may be applicable to food matrices
18, 19
. 
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3.3 Screening Methods-Biological 
 
3.3.1 Enzyme Immunoassay 
 
There are two classifications for the enzyme immunoassays based on the presence 
of the enzyme labelled antigen. The heterogeneous assay where the enzyme-labelled 
antigen or antibody is separated from the antibody-antigen complex prior to measurement 
of enzyme activity in both e.g. enzyme linked immunoassay (ELISA). The homogenous 
assay where the enzyme-labelled antigen or antibody is measured in the presence of the 
antibody-antigen complex e.g. enzyme multiplied immunoassay technique (EMIT). 
A rapid and sensitive screening ELISA for gentamicin in swine tissues was 
developed and reported an analysis time less than 45 min, excluding coating and 
blocking, with negligible cross-reactivity with other aminoglycosides
20
. LOD values 
ranged from 2.7–6.2 µg kg-1 in the different tissues and recoveries were between 90 and 
101% in muscle, 77 and 84% in liver and 65 and 75% in kidney
20
. A report by Haasnoot 
et al.,
21
 described the detection of gentamicin, neomycin, streptomycin and 
dihydrostreptomycin using three ELISA assays for applications in milk and kidney 
samples. The detection limits were 0.7-5.1 µg L
-1
 and the recoveries were 47-78% for 
milk and 70-96% for kidney. Real samples were taken and analysed from the kidneys of 
healthy pigs (n=124) and milk (n = 776). The aminoglycoside residues found were all 
below the established MRLs.  
An electrochemical ELISA for the detection of two macrolides (erythromycin and 
tylosin) in bovine muscle has been reported
22
. The detection limit of the assay was 0.4 µg 
L
-1
 for erythromycin and 4.0 µg L
-1
 for tylosin. Results were confirmed by LC-MS/MS. 
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3.3.2 Microbiological Assay 
 
An advantage of the microbiological tests is that they are inexpensive, easy to 
perform on a large scale and they possess a wide, non-specific spectrum in sensitivity
23
, 
however, a comparative study carried out by Sachetelli et al.,
24
 on tobramycin standards/ 
samples by ELISA, HPLC and microbiological assay found that the M-agar assay 
resulted in an over-estimation of the actual quantity in comparison with the other 
procedures. The aminoglycosides are commonly screened by the four-plate test (FPT) in 
the EU.  There are many drawbacks with the four-plate test such as the fact that it takes at 
least six hours before the results are known
13
. 
 
3.4 Quantitative Methods of Analysis 
3.4.1 Introduction 
Chromatography can be defined as the separation of molecules by differential 
migration, i.e. separation is achieved on the basis of different speeds of transportation for 
different molecules
25
. The most common way to classify the different chromatographic 
techniques is by the nature of the phase involved for e.g. a gas in the case of gas 
chromatography or a liquid in the case of liquid chromatography. For the 
aminoglycosides and macrolides, the focus of this review will be on liquid 
chromatography. 
Separation is achieved on a chromatographic column where there are two 
chromatographic phases: the mobile phase and the stationary phase.  Depending on the 
polarity of the sample the chromatography is described as normal-phase or reversed-
phase. With the addition of pairing agents it is referred to as ion-exchange or ion-pair 
chromatography. In normal phase chromatography, the sample is soluble in non-polar 
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solvent such as n-hexane as mobile phase and the stationary phase is more polar for e.g.   
In reverse phase chromatography, the sample is polar and therefore the mobile phase is 
polar and the stationary phase less polar for e.g. C18. Further sub-division by detector 
type will also be discussed with the main focus on methods that use mass spectrometric 
detection. 
In the case of the aminoglycosides and macrolides, group B compounds, where 
quantitative analysis at the MRL and lower is required, mass spectral detection can be 
employed. When a confirmatory assay for antibiotic residues in food is required, the 
method must provide information on the chemical structure of the analyte. A paper by 
Rivier describes the criteria for the identification of compounds by LC-MS and LC-
MS/MS in order to comply with the EU criteria for trace level organic analysis
26
.  
Mass spectrometry is the detection method of choice for the aminoglycosides due 
to the lack of chromophores and fluorophores in the molecule
27
. The mass spectrometer is 
designed to perform three basic functions: vaporise volatile compounds, to produce ions 
or neutrals from the vaporised gas-phase compounds and to separate/ detect these ions on 
a mass-to-charge ratio (m/ze). Generally the charge z is one because usually the ions are 
singly charged. The charge of one electron is a constant and therefore m/z gives the mass 
of the ion. When an array of ions is separated and recorded this is known as the mass 
spectrum with the most abundant ion, the molecular ion equal to the molecular weight
16
.  
There are many types of mass spectrometers available which can perform MS 
analysis for e.g. magnetic sector instruments which are used when ions of one mass unit 
are to be separated, or time-of-flight instruments where ions are separated over a given 
distance where the larger the mass the lower the velocity and hence the longer the time of 
flight over the given distance
16
. For MS–MS (MRM) methods, two types of mass 
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spectrometers are available: triple quadrupole and ion trap mass spectrometer or a hybrid 
of both. Triple quadrupole instruments produce ions with collision induced fragmentation 
for MS–MS (e.g. daughter ions for MRM) while, ion trap mass spectrometer can produce 
MS
n
 fragment ion (e.g. grand daughter ions). In the case of group B compounds, where 
quantitative analysis about the MRL is required, quadrupole or ion trap instruments can 
be employed. De Wash et al., discussed the advantages and the disadvantages of these 
two types of instruments by considering the analysis of sedative residues and the 
comparison of the lower LOD versus linearity.  
Direct mass spectral analysis of the aminoglycosides is difficult due to their 
thermal lability. It is possible to use thermospray ionisation to volatise and ionise the 
compounds from chromatographic eluents however it is difficult to get to low detection 
limits
29
 A summary of some of the most relevant LC-based analytical methods, many 
with mass spectral detection, published for the aminoglycosides and macrolides can be 
seen in Tables 1.5 & 1.6. 
 
3.4.2 Aminoglycosides 
There are a large number of HPLC methods available in the literature for the 
aminoglycosides and macrolides. Analysis of the aminoglycosides by HPLC has been 
dealt with in a number of review papers most recently by Stead
2
. Therefore in this review 
the focus will be given to post 2000 published methods. 
Many authors have overcome the problem of a lack of UV chromophore or 
fluorophore for the aminoglycosides by using derivatising agents for detection by 
fluorescence
30, 31, 32, 33
 or UV absorbance
34
. Derivatisation steps however render the 
analytical process more time consuming and may even introduce impurities. Another 
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problem associated with derivatisation is the possibility of the derivatives themselves 
degrading within a few hours after formation. Limits of detection using LC-fluorescence 
methods can be low for aminoglycosides in foods e.g. 7.5-15 µg kg
-1 
for streptomycin and 
dihydrostreptomycin in honey, milk, eggs and liver
30
 and 15 µg L
-1
 for gentamicin in 
milk
32
. Indirect UV or fluorescence methods have also been employed for determining 
the aminoglycosides, though not in foods
35, 11
. 
Instead of an optical technique, evaporative light scattering detection (ELSD) can 
be employed. ELSD offers sensitive, universal detection of any sample less volatile than 
the mobile phase it is in, and both chromophores and non-chromophores can be 
detected
36
. A HPLC method combined with ELSD capable of analysing four 
aminoglycosides including amikacin, neomycin, streptomycin and tobramycin has been 
described
37
. In this publication, the response for all four antibiotics was much improved 
when detected by ELSD as opposed to UV @ 220nm. Enhancement techniques for ELSD 
method development are available
36
. Since the chromatographic requirements are similar, 
methods developed with ELSD are easily transferable to MS
38
. Rapid and simple 
methods for the separation and quantitation of gentamicin and neomycin by HPLC 
coupled with ELSD have been developed for pharmaceutical preparations
39, 40
.  
Manyanga et al., compared a number of LC methods for the analysis of 
gentamicin and found, on the basis of selectivity, sensitivity and ease of use, that LC-
ELSD or LC with pulsed electrochemical detection (PED) were best
41
. It was also shown 
that method transfer between PED and ELSD is not straightforward. LC methods 
combined with electrochemical detection have been reported for other aminoglycosides
42
. 
Cai et al., employed pulsed amperometric detection after ion-exchange chromatography 
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for determination of three aminoglycosides in milk. Detection limits between 5 and 47 g 
L
-1
 were obtained
43
. 
Mass spectrometry is the detection method of choice for the aminoglycosides due 
to the lack of chromophores and fluorophores in the molecule. It offers the advantages of 
sensitivity and confirmation of identity. However, direct mass spectral determination of 
the aminoglycosides can be difficult due to their thermal lability. The ionisation mode of 
choice for the production of the ions for residue determination is atmospheric pressure 
ionisation (API). This technique, coupled to high-performance liquid chromatography 
and tandem mass spectrometry (LC–MS/MS) has heralded a new era in qualitative and 
quantitative determination of veterinary drug residues
44
. API techniques include both 
electrospray ionisation (ESI) and atmospheric pressure chemical ionisation (APCI) and 
enable the determination of compounds with a range of molecular masses as well as non-
volatile substances without a need to derivatise. This technique, based on triple 
quadrupole mass spectrometer and ion trap technologies has become more accessible and 
affordable to veterinary residue control laboratories
44
. The first mass spectral method 
which met the U.S. Centre for Veterinary Medicine (CVM) criteria for regulatory 
compliance was a multi-residue confirmation of six aminoglycoside antibiotics in bovine 
kidney using ion spray combined with tandem MS detection
45
. The method yielded limits 
of detection of 25 µg kg
-1
 for gentamicin and neomycin in kidney.   
A sensitive method for the determination of streptomycin and 
dihydrostreptomycin in milk and honey was developed using liquid chromatography-
tandem mass spectrometry (LC-MS/MS)
46
. The method was optimised in regard to 
sensitivity and chromatographic efficiency, and validated by a procedure consistent with 
EU directive 2002/657
47
. The mass spectrometer conditions were optimised while 
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infusing a 0.2 mg L
-1
 aqueous solution of the analytes, acidified with 0.1% formic acid. 
Streptomycin and dihydrostreptomycin generated a similar mass spectrum. The fragments 
m/z 263, 246, 221, 176 and 407 were found to be the most abundant transitions of the 
respective protonated molecular ions (m/z 582.1 for streptomcyin and m/z 584.2 for 
dihydrostreptomycin) to m/z 263 used for screening and quantification, while the ratios 
with the product ion m/z 246 were used for confirmation of the identity. The LOQ of 
streptomycin was 2 µg kg
-1
 in honey and 10 µg kg
-1
 in milk and the values for 
dihydrostreptomycin were a factor of two lower again
46
. 
An LC-MS procedure for determining nine widely used aminoglycoside 
antibiotics in bovine milk was developed with LOQ values between 2 µg L
-1
 (apramycin) 
and 13 µg L
-1
 (streptomycin)
48
. Extraction was carried out using matrix solid-phase 
dispersion (MSPD) followed by a gradient LC system using increasing methanol 
concentration. Heptafluorobutyric acid was included in the mobile phase as an ion pair 
agent. Detection was carried out in multi reaction-monitoring (MRM) mode and 
quantitation performed by selecting at least two fragmentation reactions for each analyte. 
Table 3.1 shows the mass spectral conditions and individual limits of quantitation. Babin 
et al., reported an even more sensitive LC-MS/MS method for the determination of 
aminoglycosides in food where the LOD values were between 0.1 and 0.4 µg kg
-1 
in 
various
 
tissue samples
49
. 
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Table 3.1: Time-scheduled MRM conditions for detecting 
aminoglycoside antibiotics
48
  
Compound MRM transition 
(m/z) 
Cone 
voltage (V) 
Collision 
energy (eV) 
LOQ  
µg kg
-1
 
Spectinomycin 351 > 315, 333 32 20 5 
Dihydrostreptomycin 293 > 176, 409 20 12 3 
Streptomycin 308 > 176, 263 20 15 13 
Aminosidine 309 > 161, 455 15 12 – 
Apramycin 271 > 163, 217 15 12 2 
Gentamicin C1a 226 > 129, 322 10 6 5 
Gentamicin C2, C2a 233 > 126,143, 322 12 6 7 
Gentamicin C1 240 > 139,157, 322 15 10 6 
Neomycin B 308 > 161, 455 15 10 4 
 
3.4.3 Macrolides 
The macrolides do contain chromophores and hence quantitative, direct UV 
determination is possible. The determination of seven macrolides in sheep‟s milk has 
been described using LC–DAD50. Erythromycin and roxythromycin were quantified at 
210 nm, josamycin and spiramycin at 231 nm, and tylosin at 287 nm. LODs ranged from 
24 to 72 µg kg
-1
. Another study using LC-DAD was shown to be capable of determining 
seven macrolides in animal liver and kidney samples
51
. The analytes were separated using 
a gradient elution system with an aqueous phosphate/phosphoric acid buffer (pH 3.5) for 
mobile phase A and acetonitrile for mobile phase B. Validation was carried out according 
to the European Commission Decision 657/2002
47
.  
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When the results were compared to those obtained by LC-MS detection in 
selected-ion monitoring (SIM) mode, the LC-DAD method was found to be robust, 
selective and stable. The LC-DAD method was found to be sensitive enough for detecting 
macrolides in liver samples with LOD values at or close to the MRLs but the LOD values 
were ten times lower using LC-MS (15-50 µg kg
-1
). The method was applied to rabbit 
liver samples (see Figure 3.1). An LC-UV method for determination of spiramycin and 
tylosin in feedstuffs yielded detection limits of 176 and 118 µg kg
-1 
respectively
52
. 
 
Figure 3.1: SIM chromatograms corresponding to the extract of rabbit liver sample 
where tilmicosin (1) was found at 250 µg kg
-1
and erythromycin (2) at 168 µg kg
-1 (51)
 
(Berrada 2007) 
LC-MS using electrospray ionisation has been used to successfully determine 
seven macrolides in chicken muscle
53
. The protonated molecular ion was used for 
quantitation purposes under selected ion monitoring (SIM) mode. Detection limits ranged 
from 1-20 µg L
-1
.  
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Table 3.2: Typical ions detected for macrolide antibiotics using LC–
ESI-MS
56
 
Compound Mw Base peak ions 
(amu) 
Other main ion 
Masses (amu) 
Erythromycin 733.9 734.5 (M+H)
+
 716.4, 576.3 
Oleandomycin 688.9 688.4 (M+H)
+
 670.4, 544.3 
Kitasamycin 771.9 772.5 (M+H)
+
 702.5, 558.3 
Josamycin 828.0 828.5 (M+H)
+
 860.4, 786.4 
Mirosamicin 727.9 728.4 (M+H)
+
 554.3 
Spiramycin 843.1 422.3 (M+2H)
2+
 843.5, 699.5, 540.3 
Neospiramycin 698.8 350.2 (M+2H)
2+
 721.5, 699.5, 540.3 
Tilmicosin 869.2 435.3 (M+2H)
2+
 869.5, 695.5 
Tylosin 916.1 916.5 (M+2H)
2+
 742.3, 582.3 
 
A confirmatory method for three macrolides using micro-LC-MS/MS in bovine 
tissues was published in 2001
54
. This method used an atmospheric pressure source with 
an ion spray interface to detect molecular ions [M+2H]
2+
 at m/z 435 for tilmicosin, and 
[M+H]
+
 ions at m/z 734 for erythromycin and 918 for tylosin. Two diagnostic daughter 
ions for each compound were studied to fulfil the confirmation requirements. LOQ values 
in kidney, liver and muscle ranged from 20-150 µg kg
-1
. An LC-tandem mass 
spectrometric method for the determination of tylosin in honey yielded an LOD and LOQ 
of < 3 µg kg
-1 
and <
 
5 µg kg
-1 
respectively
55
.  
  69 
 
 
 
Figure 3.2: Typical LC chromatograms of a standard mixture 0.05 µg mL (Horie et 
al., 2003) 
56
 
The assay, developed for the control of unauthorised use of antibiotics in bee-
keeping, was validated according to the guidelines laid down by Commission Decision 
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2002/657/EC
47
. Another LC–MS method for determination of eight macrolides in meat 
and fish samples resulted in LOQ values of 10 g kg
−1
 (Table 3.2)
 56
. A total ion current 
(TIC) trace and extracted ion chromatograms for these antibiotics are shown in Figure 
3.2. 
In recent years, sensitivity has improved using LC-MS techniques with detection 
limits less than 1 µg kg
-1 
being reported for some macrolides in food matrices
57, 58,  59
. 
Building on analytical methods reported previously by the author, Wang and Leung 
compared two LC-MS assays for the determination of six macrolides in eggs, milk and 
honey
58
. The first technique was UPLC-QTof MS with an electrospray interface, which 
allowed unambiguous confirmation of positive findings and identification of degradation 
products but was not as sensitive as LC-MS/MS. The second technique was a triple 
quadrupole LC-MS/MS, which gave better repeatability and lower LOD concentrations 
of 0.01-0.5 µg kg
-1
.   
 
Summary 
This chapter describes the various analytical methods for the determination of 
aminoglycosides and macrolides in food matrices focusing mainly on methods published 
in the past decade. Extraction of these two classes of antibiotics from food has also been 
explored. This is a very important area for the monitoring of veterinary residues in 
agriculture as there are so many different compounds and matrices required to be 
monitored under the legislation and their concentration levels are getting lower all the 
time. Despite the activity in this area of research, there still exist many gaps for certain 
matrices and species that residue laboratories are required to monitor in their national 
residue plans. With this in mind, multi-residue „catch-all‟ methods or even combination 
methods for both aminoglycosides and macrolides using definitive techniques such as 
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LC-MS are highly appealing in terms of fulfilling the legislation requirements as well as 
their high throughput and sensitivity. 
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Chapter 4: Development and optimisation of an analytical 
assay for the macrolide and aminoglycoside classes of 
antibiotics using UPLC-MS/MS 
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4.1 Introduction 
This study on a number of antibiotics from the macrolide and aminoglycoside 
families was carried out using ultra-performance liquid chromatography (UPLC) with a 
triple quadrupole tandem mass spectrometer as a detector. The optimisation of the mass 
spectrometer, dwell times, cone voltages, flow rates of gas is discussed in detail and the 
chromatographic conditions that were explored discussed.  
This study outlines the extraction and optimisation of a UPLC method, and the 
development of a mass spectroscopy method for a number of antibiotics from the 
macrolide and aminoglycoside family of antibiotics in bovine muscle. These antibiotics 
are approved for use within strict guidelines set down in Irish legislation and hence 
screening of animal products such as meat, milk, and eggs to ensure that the legislation is 
adhered to be very important. Analysis of positive screening tests for aminoglycosides 
and macrolide residues in animal products must adhere to Commission Decision 
2002/657/EC
1
 where suitable confirmatory methods are based on chromatographic 
analysis using spectrometric detection. The maximum residue limits (MRLs) allowed is 
very low and hence it can be challenging to achieve the sensitivity required in an assay 
that can determine a number of compounds simultaneously. These analytes are polar, 
resistant to acids, bases and heat and are not extensively bound to proteins
2
. They are 
found to adsorb to glass. 
 A number of analytes from the macrolide and aminoglycoside groups were 
chosen, the individual standards were tuned in the mass spectrometer and then a mixture 
of the analytes was injected onto the analytical column using a gradient elution system 
for separation. A major advantage of UPLC technology over conventional HPLC is the 
use of sub 2µm particles which improve resolution, allow for shorter run times thereby 
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reducing solvent use, costs and waste
3
.  
 The objective of this study is to present a method that allows for the quantitation 
of a number of different compounds from the aminoglycoside and macrolide groups 
together in a mixture in an animal tissue. The development of this method and the various 
parameters for optimisation are also presented and discussed. 
 
4.2. Experimental 
4.2.1  Materials and Reagents 
The following antibiotics were purchased from Sigma-Aldrich Corporation, 
tobramycin (89549), apramycin sulfate (A2024), kanamycin sulfate (60616), 
dihydrostreptomycin sesquisulfate (37386), spectinomycin dihydrochloride pentahydrate 
(85555), streptomycin sulfate (2158X), spiramycin mixture of I, II and III (S-9132), 
tylosin tartrate (T-6134), roxithromycin (R4393), lincomycin (62143) and paromomycin 
sulfate (76261). 
The following HPLC grade solvents were purchased from Fisher Scientific, 
methanol, acetonitrile and ultra-pure water. Negative (macrolide and aminoglycoside 
free) bovine muscle was sourced from abbotstown farm and screened in-house using the 
6-plate microbiological screen to ensure negativity, then homogenised and divided into 
5g individual portions. Heptafluorobutyric acid (HFBA) was purchased from Sigma-
Aldrich Corporation. 
Various Waters Oasis
®
 solid phase extraction cartridges used were WCX, WAX, 
MCX and MAX that were all purchased from Waters Chromatography, Ireland. Varian 
solid phase extraction cartridges used were the bond Elut LRC-SCX 500mg part number 
12113039 and Varian bond Elut C18 200mg/ 3mL part number 35402 and were 
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purchased from JVA Analytical. 
 
4.2.2 UPLC and Mass spectrometer 
The Ultra performance liquid chromatography system (UPLC) was a Waters 
Acquity UPLC
®
 system with a 2.1 x 50mm (1.7µm) C18 Acquity UPLC
®
 BEH column, 
Acquity Sample Organiser, In-line degasser AF, Column Manager and Heater/ Cooler, 
Binary Solvent Manager and Sample Manager. Data was processed using Waters 
Masslynx
TM
 software. The mass spectrometer used was a Waters Quattro Premier
TM
 XE 
tandem quadrupole mass spectrometer utilising T-wave
TM
 collision cell, multi-mode 
ionisation and rapid polarity switching technologies. 
4.2.3  Extraction  
 The extraction equipment used consisted of a REAX 2 overhead shaker together 
with a Heidolph test tube shaker, a Techne sample concentrator FSC 400D with Techne 
Dri-block heater DB-3 with 127mm needles and insert blocks were purchased from 
Lennox Chemicals Ltd. The vacuum chamber was a VacElut 20 purchased from JVA 
Analytical and the Laboport vacuum/ pressure diaphram self drying pump was purchased 
from Carl Stuart Limited. 
4.2.4  Preparation of Standards and Samples 
4.2.4.1  Standard Solutions 
Stock solutions (500µg/mL) of spiramycin, tobramycin, apramycin, kanamycin, 
dihydrostreptomycin, lincomycin, spectinomycin, tylosin, and roxithromycin were 
prepared in methanol. Stock solutions (500µg/mL) of streptomycin and paromomycin 
were prepared in ultra-pure water. Mixed standard solutions at 100ng/mL, 200ng/mL, 
300ng/mL, 500ng/mL and 1000ng/mL were diluted from stocks in water. All standards 
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were prepared in polypropylene volumetric units and stored in polypropylene amber 
storage jars at 4ºC. 
4.2.4.2  Matrix Samples 
Homogenised muscle samples (2g) were weighed and placed in 50mL 
polypropylene centrifuge tubes. Each tube was labelled with weight and date and stored 
at -20ºC until used. Matrix samples were spiked at appropriate levels using mixed 
standard solutions immediately prior to extraction. Samples were then de-proteinised by 
adding 10mL of either 5% trichloroacetic acid or 5% ammonium hydroxide and placed 
on a shaker for 10 minutes. The samples were then centrifuged at 10,000rpm for 10 
minutes and a 3mL aliquot was transferred to the solid phase extraction cartridge. 
4.2.5  Assay Conditions 
4.2.5.1  Extraction/ Clean-up Protocol 
 Cartridges were conditioned with 3mL methanol followed by an equilibration step 
with 3mL water. The 3mL sample was loaded onto the cartridge and the cartridge was 
washed with 3mL water. The analytes were then eluted in either 3mL methanol or 3mL 
of a 2% formic acid solution in methanol. This eluate was evaporated under nitrogen on a 
heating block set at ~45ºC and then re-constituted in 300l water. 
 4.2.5.2  UPLC  Method 
Gradient elution was used with solvent A (ultra-pure water with 10mM HFBA) 
and solvent B (100% methanol or 100% acetonitrile, where indicated) as follows: T0 
90/10, T0.5 90/10, T1.0 50/50, T2.5 50/50 T4.0 40/60 T5.0 40/60, T5.5 90/10, T6.0 90/10. The 
system was conditioned with 15% solvent B for 1 hour prior to use on each day or until a 
delta pressure of <40psi was observed on the Solvent Manager. The mobile phase was 
degassed and filtered by passing through a 0.45µm pore size membrane filter (Milipore, 
  81 
 
Milford, MA, USA) prior to use and further degassed with the in-line degasser. The flow 
rate was 0.450 mL min
-1
. All injections were performed on column at temperature of 
35ºC with injection volumes of 10 to 20µl as indicated. 
 4.2.5.3  MS Conditions 
Tuning for all analytes was carried out for the mass spectrometer with the 
optimised conditions as follows: Capillary (kV) 3.5, Extractor (V) 4.00, RF lens (V) 0.4, 
Source Temperature (ºC) 120, Desolvation Temperature (ºC) 350, Cone Gas Flow (L/Hr) 
200, Desolvation Gas Flow (L/Hr) 900, Ion Energy MS1 0.8 and Ion Energy MS2 1.0 
Table 4.1: Parent and Daughter Ions with optimised collision and cone 
voltages 
Analytes Parent Ion 
(M)+ 
Daughter 
Ions 
Collision 
(eV) 
Cone 
(V) 
Tylosin 916.5 174.2 & 101.4 40 & 45 50 
Roxithromycin 837.4 158.4 & 679.5 30 & 20 30 
Streptomycin 582.1 263.2 & 176.1 35 & 40 60 
Dihydrostreptomycin 584.1 246.2 & 263.1 35 & 30 50 
Paromomycin 616.2 163.2 & 203.2 40 & 40 45 
Spiramycin 843.5 174.2 & 101.2 40 & 40 40 
Spectinomycin 333.2 98.1 & 116.1 30 & 25 55 
Lincomycin 407.2 126.4 & 359.2 30 & 20 40 
Kanamycin 485.2 163.0 & 205.2 30 & 30 30 
Apramycin 540.2 217.2 & 378.2 30 & 20 55 
Tobramycin 468.2 163.2 & 205.3 25 & 25 30 
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4.3.  Results and Discussion 
4.3.1 Development of Extraction Protocol 
 As discussed in section 2.3, the macrolides and aminoglycosides are basic 
analytes with known pkA‟s ranging from 5.4 for apramycin (one of four protons) to 9.5 
for roxithromycin. A number of different solid phase extraction cartridges were tested. 
The following Waters cartridges were compared:  
 HLB: Hydrophilic- lipophilic sorbent for all compounds.  
 MCX: A mixed-mode Cation exchange and reverse-phase sorbent suitable for bases, 
high selectivity for basic compounds. 
 MAX: A mixed-mode Anion exchange and reverse-phase sorbent suitable for acids, 
high selectivity for acidic compounds. 
 WCX: A mixed-mode Cation exchange and reverse-phase sorbent with a high 
selectivity for strong bases. 
 WAX: A mixed-mode Anion exchange and reverse-phase sorbent with a high 
selectivity for strong acids. 
 
4.3.2 Development of UPLC Method 
4.3.2.1  Mobile Phase Composition 
 During the course of the laboratory work for this study, the instrument chosen was 
a Waters Acquity UPLC coupled with a Waters Premier XE mass spectrometer. This 
equipment was designed to allow for fast sensitive analysis of samples thus proving an 
excellent choice for method development especially in terms of the sheer number of 
anlaytes proposed in this study. 
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 Initially an isocratic mobile phase of mobile phase A ultra-pure water (0.2% 
acetic) with mobile phase B acetonitrile (0.2% acetic) was chosen to look at some 
individual analytes. Tylosin at a level of 20ng on column was run through the Acquity 
column at a number of different conditions from 85% A down to 30% A. Retention was 
found to improve at the lower aqueous level as these conditions allowed for better 
interaction between analyte and the non-polar stationary phase. Retention of streptomycin 
and tilmicosin was also observed using this mobile phase.  
 
 
Figure 4.1: Standard mix of aminoglycoside and macrolides at their MRL levels, 
50ppb-1000ppb.  Peaks 1 to 11: Spectinomycin, lincomycin, streptomycin, 
dihydrostreptomycin, kanamycin, apramycin, tobramycin, paromomycin, 
spiramycin, tylosin and roxithromycin.  
1 
2 
3 
5 
6 
8 
9 
10 
11 
7 
4 
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 The aminoglycosides and macrolides eluted in general according to their polarities 
with spectinomycin of highest polarity eluting first and roxithromycin eluting last (Figure 
4.1) as expected using reverse phase chromatography with the following UPLC 
Conditions: Flow Rate: 0.3mL/min, Solvent A: 10mM HFBA, Solvent B: Acetonitrile, 
Gradient: Initial 90%A, 4.5min 50%, 8.5min 30%, 9.5min 90%, 10.5min 90%.  
 Gentamicin was a more difficult analyte to work with as it was less polar than the 
others. No retention of gentamicin was seen using the same mobile phase conditions 
above. Methanol was substituted for acetonitrile as mobile phase B to see if the slightly 
more polar methanol would improve the result for this analyte. However no retention was 
achieved. 
 
4.3.2.2  Use of Ion-pair reagent 
 A literature review for these analytes provided a solution for the problem with 
gentamicin in the form of the use of an ion-pairing agent. The effects of increasing 
amounts of pentafluoroporpionc acid (PFPA) from 0.2% to 0.4% were found to cause 
more retention of the aminoglycosdies on a reversed phase column
4
 (Manis 2001). The 
retention of the aminoglycosides on reversed-phase columns increased with ion-paring 
chain length for e.g. HFBA > PFPA
5
 (Heller 2000). Therefore, a mobile phase containing 
10mM HFBA in ultra-pre water was chosen as mobile phase A and 100% methanol for 
mobile phase B in a ratio of (50:50) resulted in a broad peak at ~2 minutes observed for 
gentamicin.  
 In the case of tilmicosin, which is more polar to gentamicin, a (50:50) ratio 
resulted in less retention as the peak eluted very quickly in the mobile phase, changing to 
a less polar mobile phase ratio of (30:70) improved retention (Figure 4.2). The peak 
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quality characteristics (Table 4.2) were also improved with the kurtosis value closer to a 
more normal peak shape of 0 for peak A compared to peak B.   
 
Figure 4.2: Tilmicosin standard @ 10ng/l, Mobile phase 10mM HFBA/ methanol 
Chromatogram A (50:50) and chromatogram B (30:70) 
 
The Waters Acquity UPLC
®
 ,columns are designed to combine faster seperations 
with high resolution. These columns are capable of running under high pressure 
conditions of up to 15000 psi (1000 bar) and are available in many different 
configurations and chemistries. 
Table 4.2:  Peak quality factors for Tilmicosin standard @ 10ng/l 
Chromatogram Skewness Kurtosis Signal/ Noise 
 
Chromatogram A 0.128 -1.077 10 
Chromatogram B  0.229 0.430 239 
Mobile phases: chromatogram A 10mM HFBA/ methanol (50:50) and chromatogram B 
(30:70) 
10ng/ul Til Std
Time
0.25 0.50 0.75 1.00 1.25 1.50 1.75 2.00 2.25 2.50 2.75 3.00 3.25 3.50 3.75 4.00 4.25 4.50 4.75
%
0
100
0.25 0.50 0.75 1.00 1.25 1.50 1.75 2.00 2.25 2.50 2.75 3.00 3.25 3.50 3.75 4.00 4.25 4.50 4.75
%
0
100
0.11
2.182.15
0.58
0.88 1.521.111.03 1.14
1.60
1.85
2.34 2.37 2.65 3.853.42
3.35
2.94 2.98 3.69
3.49 4.04 4.714.13 4.454.38 4.49 4.81
0.58
B 
A 
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Once all the individual analytes had been assessed individually a mixture of all 8 
analytes in 30% methanol was prepared at 10 ng/l and 5 ng/l respectively. A gradient 
mixture of the mobile phases was employed to look at separating the analytes. Although 
there is some variation in the polarities of the analytes the known pka‟s lie in a close 
range from 7.1 for tylosin to 9.5 for roxithromycin
6
 (Merck Index, 13
th
 edition) so the 
peaks eluted in quite a close group between 1.97 min and 5.09 min for 100 ng on column.  
  
 
Figure 4.3: Illustration of peak tailing for tilmicosin. Chromatogram A shows 
tilmicosin eluting in ultra-pure water (0.2% acetic: acetonitrile (0.2% acetic) 
(30:70), B shows elution in 10 mM HFBA: methanol (50:50) and C 10 mM HFBA: 
methanol (30:70). 
  
 Peak shape was found to be affected by changes in the mobile phase polarity and 
the addition of an ion-pairing agent (Figure 4.3). The tailing for tilmicosin was improved 
with the addition of the ion-pairing agent HFBA compared with acetic acid (Figure 4.3, 
chromatograms A and C) and further when the mobile phase went from 50% aqueous 
1ng/ul Til Std
Time
0.25 0.50 0.75 1.00 1.25 1.50 1.75 2.00 2.25 2.50 2.75 3.00 3.25 3.50 3.75 4.00 4.25 4.50 4.75
%
0
100
0.25 0.50 0.75 1.00 1.25 1.50 1.75 2.00 2.25 2.50 2.75 3.00 3.25 3.50 3.75 4.00 4.25 4.50 4.75
%
0
100
0.25 0.50 0.75 1.00 1.25 1.50 1.75 2.00 2.25 2.50 2.75 3.00 3.25 3.50 3.75 4.00 4.25 4.50 4.75
%
0
100
1.12
0.11
2.182.15
0.58 0.88 1.521.11
1.03
1.14
1.60
1.85
2.34 2.37 2.65 3.853.42
3.35
2.94 2.98 3.69
3.49 4.04 4.714.13 4.454.38 4.49
4.81
0.58
A 
B 
C 
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(Figure 4.3, chromatograms B) to 30% aqueous (Figure 4.4, chromatograms B). The peak 
quality criteria also reflect this (Table 4.3) with the kurtosis and skewness closest to the 
expected normal distribution of 0 for chromatogram C. 
 
Table 4.3:  Peak quality factors Tilmicosin standard at 10ng/l. 
Chromatogram Skewness Kurtosis Signal/ Noise 
    
Chromatogram A 1.585 2.071 586 
Chromatogram B 0.128 -1.077 10 
Chromatogram C 0.229 0.430 239 
Chromatogram A ultra-pure water (0.2% acetic: acetonitrile (0.2% acetic) (30:70), B 10 
mM HFBA: methanol (50:50) and C 10 mM HFBA: methanol (30:70). 
 
4.3.2.3  Introducing Matrix and Injecting mixed standards in matrix 
 As each analyte has an individual MRL, a mixture of the analytes were prepared to 
reflect the levels of interest from 50 g/L to 250 g/L separation of all 7 analytes was 
possible (Figure 4.4).    
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Figure 4.4: Extracted bovine muscle sample. 8 analytes extracted from bovine 
muscle at 50 ppb to 250 ppb, from bottom to top, lincomycin, dihydrostreptomycin, 
streptomycin, spiramycin, tylosin, erythromycin and roxithromycin. 
 
4.3.3 Development of  MS Conditions 
4.3.3.1 MS tuning and optimisation for parent and daughter ions 
  Mass spectrometry is the detection method of choice for the aminoglycosides due 
to a lack of chromophores and fluorophores in the molecule ruling out the use of UV or 
fluorescence detection without the use of derivatisation agents as demonstrated by many 
authors
7, 8, 9, 10
 or UV absorbance
11
. The macrolides on the other hand do contain 
chromophores and fluoresce but since the aim of this study was to determine the 
aminoglycosides and macrolides as one group mass spectrometry was the detection 
method of choice. Mass spectral data offers the advantages of sensitivity and 
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confirmation of identity, however, direct mass spectral determination of the 
aminoglycosides can be difficult due to their thermal lability
12
.  
A sample solution of each individual analyte in methanol was infused directly into 
the MS through the capillary at a flow rate of 40µl/min. Mobile phase was mixed with 
analyte at a rate of 0.450 mL min
-1
 through the T-piece.  The mass range of interest i.e. 
the mass of the parent ion (M+) was focused on and the various settings for the 
instrument such as cone voltage, capillary voltage, gas flows and temperatures, optimised 
to get the best response for each parent ion. An example of the tuning spectrum for 
tylosin with mass 917 can be seen in Figure 4.5.  
 
 
Figure 4.5: Mass spectrum of parent ion for tylosin [M
+1
] 917. 
 
Tylosin parent 917 
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The ionisation of these analytes can be difficult due to their polarity and the ratio 
for the signal to concentration can be very small in comparison to other analytes
13
. The 
aminoglycoside and macrolide analytes showed similar fragmentation patterns and the 
fragment of highest intensity used for quantification. Figure 4.6 shows the daughter ions 
produced when tylosin is fragmented.  
 
 
Figure 4.6: Mass Spectrum for daughter ions of Tylosin [M
+1
] 917 
A Multiple Reaction Monitoring (MRM) file was built for each analyte using the 
optimised conditions. Figure 4.7 shows the total ion chromatogram (TIC) and two MRM 
files for a tylosin standard at 1ng/l. This process was carried out for each analyte with 
each parent to daughter ion transition occurring under specific conditions (Table 4.1). 
 
Daughter @ 101 
Collision Energy = 45eV  
Daughter @ 174 
Collision Energy = 40eV  
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Figure 4.7: Total ion chromatogram TIC for Tylosin and daughter ion 
chromatrograms. Note: 1ng/µl in 30% methanol, infused into MS through syringe. 
 
4.3.3.2 Effects of dwell time, cone voltage and injection volumes 
Dwell times, inter-channel delays and inter scan times on the peak shapes were 
studied. In the case of gentamicin the dwell time was changed from 0.01 to 0.5 to see if 
the peak shape could be improved. A very broad peak was observed for gentamicin as 
this analyte consists of a number of different components, which are difficult to separate. 
Changes to the dwell time affect the number of scans seen across the peaks and due to the 
fact that the genatmicin peak was very broad, lowering and raising this function did not 
have an apparent effect on the peak shape. A bigger effect of changes to dwell time 
would be seen in very narrow peak with less than 15 scans across. Again for the inter 
Tylosin Parent 
Ion 916.4 
916.4>156.1  
916.4>174 
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scan and inter channel functions, changing from 0.1 to 0.05 did not appear to have much 
effect on the peak shape of gentamicin. 
 
Summary 
This method looked at a number of antibiotics from the macrolide and 
aminoglycoside families using ultra-performance liquid chromatography (UPLC) coupled 
with a triple quadrupole tandem mass spectrometer as a detector. The optimisation of the 
mass spectrometer, dwell times, cone voltages, flow rates of gas etc. was discussed in 
detail and the chromatographic conditions that were explored discussed.  
This method outlines the extraction and optimisation of a UPLC method, and the 
development of a mass spectroscopy method for a number of antibiotics from the 
macrolide and aminoglycoside family of antibiotics in bovine muscle. This method 
provides a fast and economical way for a laboratory such as this, the National Reference 
Laboratory, to carry out its functions to comply with the legislation for monitoring these 
two groups of antibiotics in animal tissues. Many possibilities exist for developing this 
research to look at other groups and/ or matrices. Much knowledge has been acquired in 
the technique of UPLC-MS/MS in terms of optimising the mass spectrometer instrument 
coditions and the UPLC chromatographic conditions.  
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5.1. Conclusion 
 This study focused on two groups of antibiotics the aminoglycosides and the 
macrolides. A thorough background was given detailing the legislation covering these 
groups and the chemical properties of these compounds in chapter 1. These compounds 
are required to be monitored in accordance with EU legislation by the National Reference 
Laboratory in Ireland, the Central Meat Control Laboratory (CMCL).  
 These antibiotics are widely used in the treatment of bacterial infections e.g. 
enteric infections. They have also been used as feed additives for growth promotion. 
Legislation monitoring these residues in live animals and animal products are given in 
Council Directive 96/23/EC3, S.I. 507/98 and Commission Decision 2002/657/EC4. 
 In order to comply with the legislation it is important for the laboratory to 
continually develop and keep up to date with scientific research. This project is part of 
improving the expertise within the laboratory and bringing on board new methods using 
state of the art instrumentation such as the Waters Acquity UPLC system.  
The aim of this project was ultimately to develop and method that would analyse 
the two groups within one analytical run. The method presented in chapter 4 outlines the 
extraction and optimisation of a UPLC method, and the development of a mass 
spectroscopy method for a number of antibiotics from the macrolide and aminoglycoside 
family of antibiotics in bovine muscle. This method is of huge benefit to the work of the 
laboratory in terms of enabling compliance with the legislation governing National 
Reference laboratories and also in terms of developing our expertise in the field of 
analytical science and keeping up to date with the latest techniques available. While this 
method did not fulfil the “catch all” ideal for both groups it did however provide a 
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starting point where a large amount of data was analysed and can be further developed to 
look at separate methods for these groups perhaps. 
Finally, the novel method will be applied to the analysis of real samples in the 
Central Meat Control laboratory which is a National Reference Laboratory (NRL) for e.g. 
bovine, ovine and porcine tissues.  
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